Shionogi & Co., Ltd. Unsponsored ADR (OTCMKTS:SGIOY - Get Free Report) shares hit a new 52-week high during mid-day trading on Tuesday . The company traded as high as $9.00 and last traded at $9.00, with a volume of 1407 shares changing hands. The stock had previously closed at $8.95.
Shionogi & Co., Ltd. Unsponsored ADR Trading Up 0.3%
The stock has a market cap of $15.19 billion, a P/E ratio of 15.17, a P/E/G ratio of 2.03 and a beta of 0.20. The company has a debt-to-equity ratio of 0.01, a quick ratio of 6.13 and a current ratio of 6.63. The stock has a 50-day moving average price of $8.62 and a 200-day moving average price of $8.06.
Shionogi & Co., Ltd. Unsponsored ADR (OTCMKTS:SGIOY - Get Free Report) last issued its quarterly earnings results on Monday, July 28th. The company reported $0.16 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.14 by $0.02. The business had revenue of $672.90 million for the quarter, compared to the consensus estimate of $719.55 million. On average, equities research analysts expect that Shionogi & Co., Ltd. Unsponsored ADR will post 0.66 EPS for the current year.
About Shionogi & Co., Ltd. Unsponsored ADR
(
Get Free Report)
Shionogi & Co, Ltd. engages in the research, development, manufacture, and distribution of pharmaceuticals, diagnostic reagents, and medical devices in Japan. It offers Fetroja, a multidrug-resistant for gram-negative bacterial infection treatment; Cabenuva and Apretude an anti-HIV and HIV prophylactic drug; Xocova an oral COVID-19 treatment drug; Finibax a carbapenem antibiotic; Xofluza, an influenza antiviral drug; and Tivicay, an anti-HIV drug.
Featured Articles
Before you consider Shionogi & Co., Ltd. Unsponsored ADR, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Shionogi & Co., Ltd. Unsponsored ADR wasn't on the list.
While Shionogi & Co., Ltd. Unsponsored ADR currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Fall 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
